Singapore: Phytophagous ladybird beetle, Henosepilachna pusillanima (Mulsant), synonym of Epilachnadodecastigma (Wiedema...
Bangalore: Dr. Reddy's Laboratories has launched Ibandronate sodium tablets (150 mg), a bioequivalent generic version of...
The regulatory environment for life sciences companies is known for its challenging nature. The framework is confusing a...
Bangalore: MERS scare swirls up in India, as Karnataka health officials and health minister Mr U T Khader confirmed a su...
Singapore: The centers will offer latest technology for diagnosing and treating cancer, and will follow the same standar...
Singapore: Foraying into South American pharmaceutical market, India based Lupin Pharmaceutical has acquired Mexico firm...
Singapore: As Asia emerges as a major engine of global economic growth, the pharmaceutical and biotechnology industries ...
Singapore: As the global investment community continues its recovery from the 2008 financial crisis, the total value of ...
Singapore: As MERS is multiplying incessantly, authorities in Indian state Andhra Pradesh, have issued an advisory to tr...
New Delhi: In a bid to move towards strict enforcement of the new drug pricing policy in India, the country's National P...
Political events in India and the government's lack of conviction on policy matters have taken their toll on India's ima...
Bangalore: The Associated Chambers of Commerce and Industry of India (ASSOCHAM) apprehends that the Supreme Court rulin...
Bangalore: Mylan has signed a definitive agreement with Strides Arcolab to acquire its generic injectable products unit,...
As a scientist-turned entrepreneur, my journey has taken a long time, with many struggles along the way. For an entrepre...
Singapore: Mr Saurabh Gupta, Principal Consultant, Healthcare Advisory Services at PricewaterhouseCoopers India speaks t...
Healthcare, biotech, pharma and life sciences are sectors that involve patient bunch of people who are willing to wait f...
Singapore: US-based BioSpecifics Technologies, a biopharmaceutical company, and its partner Auxilium Pharmaceuticals hav...
Singapore: Glenmark Pharmaceuticals has consolidated $254.45 million for the third quarter ending December 31, 2012, mar...
